An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
FBD Biologics Limited
FBD Biologics Limited
Eli Lilly and Company
Baylor College of Medicine
Pfizer
EMD Serono
Suzhou Transcenta Therapeutics Co., Ltd.
MedPacto, Inc.
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)